CSJA:FRA
CSL ADR
30,40 €
0,00%
(0,00) 1D
11-ноя., 21:36:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Mkt. cap
98,16 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
Mkt. cap
98,16 млд
Avg. vol.
0,00
Volume
0,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 миң
News stories
From web sources and news partners
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 миң
Founded1916
HeadquartersМельбурн, Виктория, Австралия
SectorHealth Care
Industry-
Websitecsl.com